P53 Invest
Overview
P53 Invest is a Norwegian healthcare investment company that identifies and invests in innovative companies, particularly in the fields of biotechnology and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Valink Therapeutics | Oct 2025 | Series Pre-A | Co-investor |
| Pacertool AS | Dec 2021 | Seed | Co-investor |
| RougeTx | Oct 2026 | Series A | Co-investor |
| Teitur Trophics | Mar 2023 | Series A | Co-investor |
| Calluna Pharma | Jan 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is P53 Invest based?
P53 Invest is headquartered in Stavanger, Norway.
When was P53 Invest founded?
P53 Invest was founded in 2018.
How many portfolio companies does P53 Invest have?
P53 Invest has 5 portfolio companies in Caplight's dataset.
What are some companies in P53 Invest's portfolio?
Portfolio companies visible on Caplight include Valink Therapeutics, Pacertool AS, RougeTx, Teitur Trophics, Calluna Pharma.
What was P53 Invest's most recent investment shown here?
P53 Invest's most recent investment in this portfolio sample was in RougeTx in 2026.
What sectors does P53 Invest focus on?
P53 Invest focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does P53 Invest focus on?
P53 Invest typically invests at the Early stage.